Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About
Portfolio Pulse from Chris Katje
Benzinga's Stock Whisper Index highlights five stocks that warrant attention. This week's stocks include Rivian Automotive (RIVN), which saw a 70% rise in shares due to strong Q2 production and delivery numbers; Recursion Pharmaceuticals (RXRX), which announced a $50 million investment by Nvidia Corporation (NVDA); Dragonfly Energy Holdings Corp (DFLI), which saw a small rally after announcing that nuCamp RV will use its products as standard equipment; Petros Pharmaceuticals (PTPI), which recently announced a $15 million private placement; and PainReform (PRFX), which saw a 40% rise in shares year-to-date.
July 14, 2023 | 2:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Dragonfly Energy Holdings Corp saw a small rally after announcing that nuCamp RV will use its products as standard equipment.
The announcement of nuCamp RV using Dragonfly Energy's products as standard equipment has led to a small rally in its shares.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
PainReform saw a 40% rise in shares year-to-date.
PainReform's shares have risen significantly year-to-date, indicating strong investor interest and confidence in the company.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Petros Pharmaceuticals recently announced a $15 million private placement.
The announcement of a $15 million private placement could boost investor confidence in Petros Pharmaceuticals, potentially leading to a rise in its stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Rivian Automotive saw a 70% rise in shares due to strong Q2 production and delivery numbers.
Rivian's strong Q2 production and delivery numbers have boosted investor confidence, leading to a significant rise in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Recursion Pharmaceuticals announced a $50 million investment by Nvidia Corporation.
The $50 million investment from Nvidia Corporation is a significant financial boost for Recursion Pharmaceuticals, which could positively impact its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100